- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
IgA Nephropathy – From Pathogenesis to Current Management
About This Event
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.
Americana
2620 Regatta Dr Ste 118
Las Vegas, NV 89128 United States + Google Map702-331-5565 View Venue WebsiteFeaturing
Rim Hadgu, PharmD, BCPS
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Dr Rim Hadgu, PharmD, BCPS is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She obtained her Doctor of Pharmacy degree from St. Louis College of Pharmacy. She completed an American Society of Health-System Pharmacists (ASHP)-Accredited PGY1 Pharmacy Residency at Xavier University of Louisiana College of Pharmacy and University Medical Center New Orleans. She also completed an ASHP-Accredited PGY2 Nephrology Pharmacy Residency at Albany College of Pharmacy and Health Sciences. Prior to joining Otsuka in October 2021, she was an Assistant Professor of Pharmacy Practice at Midwestern University College of Pharmacy, Glendale Campus where she delivered lectures, precepted Advanced Pharmacy Practice Experience students as well as PGY1 and PGY2 pharmacy residents. She also practiced as a nephrology clinical pharmacist for two years. Dr Hadgu is a Board Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties.
Dr. Samuel Kantor, MD
Nephrologists PartnerNephrologist Partner
Samuel Kantor, MD
Nephrologist Partner
Nevada Kidney Disease and Hypertension Centers*
Dr Kantor received his postgraduate training at Medical College of Pennsylvania and Hahnemann University College of Medicine in Philadelphia, PA. Dr Kantor did his fellowship training at Drexel University College of Medicine in Philadelphia, PA and was Chief Nephrology Fellow. He is a partner at Nevada Kidney Disease and Hypertension Centers in Las Vegas, NV and is a principal investigator and sub-investigator in multiple phase 2 and 3 clinical studies undertaken by the practice. Dr Kantor has been board-certified in Nephrology since 2003. He was awarded ‘Top Doctor’ Status by Las Vegas INC. Magazine in their healthcare issue in 2015, 2016, and 2023. He was also awarded ‘Top Doctor’ status by Desert Companion Magazine in 2021 and 2022.
Rim Hadgu, PharmD, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Samuel Kantor, MD is a speaker on behalf of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Related Events
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
